Skip to main content
Premium Trial:

Request an Annual Quote

Nacalai to Distribute TriLink Tools in Asia

NEW YORK (GenomeWeb News) – TriLink BioTechnologies said today that Nacalai USA will distribute TriLink's nucleic acid products in certain Asian countries.

Under the agreement, Nacalai will distribute TriLink's technologies in Japan, Singapore, South Korea, and Taiwan.

TriLink's product offerings include custom oligonucleotides, modified nucleoside triphosphates, and its CleanAmp PCR products for the diagnostic and OEM markets.

Nacalai USA is the San Diego-based subsidiary of Nacalai Tesque, of Kyoto, Japan.

The company said that the agreement will give the Asian market access to modified nucleic acid products to further advance research efforts in areas such as molecular biology and proteomics.

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.